TTelum Therapeutics — Seed (estimated) · €4.1M
Telum Therapeutics raised €4.1M in its first round to develop enzybiotics, which are therapies based on bacteriophage lytic enzymes, against multidrug-resistant bacterial infections. The money will take its lead candidate IKB206 towards the clinic. Invivo Ventures led, and Clave Capital and CDTI-Innvierte co-invested.
LeadInvivo Ventures
RoundSeed (estimated)
Announced13 Jul 2020
CityNoáin · reported Pamplona
SectorHealthtech & Bio · Biotech
Source
I
I
